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JPGN  Ved formulae are well-tolerated, effec-
and effectively promote growth in
w’s milk allergy.
dy shows that an amino acid-based
ctive in providing adequate dietary
and maintaining mineral status in
w’s milk allergy.
to the understanding of the nutri-
infants with cow’s milk allergy con-
no acid-based formula.Data on the mineral status of infants with cow’s milk allergy (CMA)
consuming an amino acid-based formula (AAF) have not been published.
The present study aims to assess mineral status of term infants age 0 to
8 months diagnosed with CMA receiving an AAF for 16 weeks. Serum
concentrations of calcium, phosphorus, chloride, sodium, potassium, mag-
nesium, and ferritin were determined in 82 subjects at baseline and in
66 subjects after 16 weeks on AAF using standard methods and evaluated
against age-specific reference ranges. In addition to this, individual esti-
mated energy and mineral intakes were compared to Adequate Intakes
defined by the European Food Safety Authority and the US Institute of
Medicine. The results of this study show that the AAF was effective in
providing an adequate mineral status in infants with CMA. The vast majority
of infants aged 0 to 6 months (formula only) and aged 6 to 12 months
(formula and complementary foods) had adequate mineral intakes.
Key Words: amino acid-based formula, calcium, cow’s milk allergy, iron,
mineral, phosphorus(JPGN 2017;65: 346–349)
ow’s milk allergy (CMA) is the most common food allergy
in infancy, affecting up to 5% of infants in their first year ofC
life (1). The symptoms of food allergy are gastrointestinal,
cutaneous, and respiratory (1). Fundamental to CMA management
is complete elimination of offending proteins. For infants who are
breast-fed, this requires mothers eliminating all cow’s milk proteinfrom their diet. If breast-feeding is not possible, a suitable cow’s
milk-free formula is required. Hypoallergenic formulae such as
extensively hydrolyzed formula (eHF) or amino acid-based formula
(AAF) should be the formula of choice (2). An eHF is recommended
for infants with mild to moderate CMA, whereas initiation with an
AAF is recommended for more severe or complex allergy or when
symptom-resolution with eHF fails (2). Dietary management of
CMA with an AAF has been proven to be well-tolerated, effective,
and safe; adequate infant growth on an AAF has widely been
reported (3–5). Data on mineral status of infants consuming
AAF have, to our knowledge, not, however, been published. Yet,
eliminating dairy products in diets of CMA infants, as well as
coexisting feeding problems, can result in removing a substantial
source of minerals, including calcium and phosphorus, which are
involved in essential body functions (6). The aim of this study was
to assess mineral status (calcium, phosphorus, chloride, sodium,
potassium, magnesium, and iron) of infants receiving an AAF for
16 weeks. In addition to this, dietary mineral intakes were estimated
and evaluated against Adequate Intakes (AIs).
METHODS
In a prospective, randomized, double-blind controlled study,
full-term infants age 0 to 8 months with confirmed Immunoglobulin
E (IgE) or non-IgE-mediated CMA were randomized to receive an
AAF (n¼ 110) with or without synbiotics (short-chain and long-
chain oligosaccharides [1.0 g/100 kcal], Bifidobacterium breve M-
16 V [2.16 109 CFU/100 kcal]) for 16 weeks (3,4). Details about
the study formulae (Neocate; SHS International Ltd., Nutricia
Advanced Medical Nutrition, Liverpool, UK) can be found in
Supplemental Digital Content, Table 1, http://links.lww.com/
MPG/B18.
CMA was diagnosed according to specified criteria listed in
Supplemental Digital Content, Table 2, http://links.lww.com/MPG/olume 65, Number 3, September 2017
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tive commercially available hypoallergenic formula before study
entry. Solid foods free of milk and other allergenic proteins
dependent on documented allergies were part of the subject’s diet
as advised by their physician. Subjects were recruited between April
2008 and March 2012 within 29 participating sites in the United SA.
Primary outcomes were growth and formula tolerance and
have been reported previously (3,4). The clinical trial was registered
as NCT00664768 and medical ethical approval was obtained by
the Chesapeake Institutional Review Board (Columbia, MD). All
parents/guardians gave written informed consent for their children
to participate.
Mineral status was assessed by standard analyses of blood
samples obtained at baseline and at 16 weeks, and included calcium,
phosphorus, chloride, sodium, potassium, magnesium, and iron
(ferritin). Furthermore, hemoglobin, albumin, and total protein were
determined. These laboratory measurements are routinely used to
assess the nutritional status of our target group (7). All blood
samples were analyzed in 1 central laboratory (Covance Central,
Laboratories Services Inc, Indianapolis, IN). Differences in blood
chemistry parameters (at baseline, week 16 and change from
baseline) between the study products have been analyzed before
and were not found to be statistically significant or clinically
relevant (3). Therefore, blood chemistry parameters are presented
for the overall population.
Average daily formula intake consumed by each subject was
recorded in 3-day food diaries at weeks 2, 4, 8, and 16 of the study.
From these intake data, individual energy and mineral intakes were
calculated based on study product composition. Energy intakes
were evaluated against Dietary Reference Values for energy of the
UK Scientific Advisory Committee on Nutrition (8) and the US
Institute of Medicine (IOM) (9). Due to the correlation between
energy requirements and energy intake, it was not possible to
estimate the prevalence of inadequate energy intake without infor-
mation on individual energy requirements (9,10). Mineral intakes
(calcium, phosphorus, chloride, sodium, potassium, magnesium,
and iron) were evaluated against AIs defined by the European FoodTABLE 1. Blood chemistry parameters at baseline (n¼82) and after 16 w
Parameter Reference value Mean (
Ca, mmol/L 2.25–2.74 2.67 (0
P, mmol/L 1.36–2.62 (<1 y) 2.05 (0
1.03–1.97 (1 y) —
Cl, mmol/L 94–112 104 (3
Na, mmol/L 132–147 140 (3
K, mmol/L 3.7–5.6 (<1 y) 5.0 (0
3.4–5.4 (1 y) —
Mg, mmol/L 0.70–0.98 (<30 day) 0.89 (0
0.66–1.03 (M; 30 day) 0.95 (0
0.78–0.98 (F; 30 day) 0.95 (0
Ferritin, mg/L 12 61 (5
Hemoglobin, g/L 100–200 (<30 day) 168 (4
100–140 (<5 mo) 115 (1
105–135 (5 mo) 119 (9
Albumin, g/L 24–48 (<30 day) 38 (2
28–48 (30 day) 39 (5
Total protein, g/L 54–74 (<3 mo) 58 (3
55–71 (3 mo) 61 (6
Mean (SD) and number (%) of infants having a mineral status below the low
AAF¼ amino acid-based formula; Ca¼ calcium; Cl¼ chloride; K¼ potassiu
www.jpgn.orgSafety Authority (EFSA) (11) and the IOM (12,13). The AI is the
daily mean nutrient intake when healthy, full-term infants are
consuming human milk, but cannot be used to estimate the pro-
portion of infants with inadequate intakes (12). Therefore, intake
was evaluated qualitatively. If median intake was above the AI, the
prevalence of inadequate intake was stated as ‘‘low’’. When this was
not the case, the adequacy of the diet could not be evaluated (‘‘no
statement’’) (10). To estimate total mineral intake, that is, intake
from both formula and complementary foods, we used published
intake data made by complementary foods (ie, all foods other than
infant formula/human milk/cow’s milk) from the UK Diet and
Nutrition Survey of Infants and Young Children (14). In this survey,
no estimates are given of the contribution of complementary foods
to intakes of phosphorus, chloride, potassium, and magnesium, and
therefore only intake data from formula are presented for these
minerals.RESULTS
Baseline characteristics of the enrolled subjects are presented
in Supplemental Digital Content, Table 3, http://links.lww.com/
MPG/B20. Average age of infants at inclusion was 4.6 2.5 months
(meanSD). Out of the 110 infants included in the study, 82 (75%)
had blood parameters analyzed at baseline and 66 (60%) after
16 weeks on AAF. Reasons for dropout are presented in Supple-
mental Digital Content 4, Figure 1, http://links.lww.com/MPG/B21.
At baseline and after 16 weeks on AAF, mean blood con-
centrations of all minerals were within the specified reference
ranges set for the corresponding ages of the infants (Table 1).
Among some minerals, there was a number of individual values at
baseline that were below the reference ranges for age, that is,
calcium (n¼ 1), phosphorus (n¼ 1), chloride (n¼ 1), sodium
(n¼ 1), and ferritin (n¼ 6), whereas at week 16 only ferritin
concentrations remained below the reference range for age for a
number of individuals (n¼ 15) (Table 1). Mean values of hemo-
globin, albumin and total protein were within reference ranges for
age at baseline and after 16 weeks (Table 1).eeks on amino acid-based formula (n¼66)
Baseline After 16 weeks on AAF
SD) n (%) Mean (SD) n (%)
.14) 1 (1%) 2.62 (0.11) 0
.25) 1 (1%) 1.97 (0.20) 0
1.86 (0.24) 0
.2) 1 (1%) 104 (2.3) 0
.3) 1 (1%) 140 (2.3) 0
.52) 0 4.6 (0.29) 0
4.6 (0.48) 0
.05) 0 0.92 (0.05) 0
.06) 0 0.95 (0.07) 0
.05) 0 0.96 (0.07) 0
5) 6 (7%) 24 (18) 15 (22%)
.6) 0 — —
1) 4 (7%) 122 (8.5) 0
.4) 2 (8%) 121 (9.0) 2 (4%)
.3) 0 —
.2) 3 (4%) 41 (3.7) 0
.4) 1 (4%)
.5) 5 (9%) 64 (4.3) 0
est range of the reference value.
m; Mg¼magnesium; Na¼ sodium; P¼ phosphorus; y¼ years.
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TABLE 2. Median (p50) intakes of minerals from formula alone for 0 to 3-month-old boys, 4 to 6-month-old boys, 0 to 3-month-old girls and 4 to
6-month-old girls compared with Adequate Intakes Set by the European Food Safety Authority and US Institute of Medicine
Boys Girls
Prevalence of
0–3-month olds 4–6-month olds 0–3-month olds 4–6-month olds EFSA AI US AI inadequate intake
Study visit 2 4 8 2 4 8 16 2 4 8 2 4 8 16
Calcium, mg 551 616 694 618 589 678 694 513 497 507 560 608 581 585 200 200 Low
Phosphorus, mg 390 436 491 438 417 480 491 363 352 359 396 431 411 414 100 100 Low
Iron, mg 7.0 7.8 8.8 7.8 7.4 8.6 8.8 6.5 6.3 6.4 9.0 9.7 9.3 9.4 0.3 0.27 Low
Chloride, mg 379 424 477 425 405 467 477 353 342 349 385 418 399 402 300 180 Low
Sodium, mg 185 207 233 208 198 228 233 172 167 170 188 205 195 197 120 120 Low
Potassium, mg 517 578 651 580 552 636 651 481 466 475 525 570 545 549 400 400 Low
Magnesium, mg 50 56 63 56 54 62 63 47 45 46 51 55 53 53 25 30 Low
AI¼ adequate intake; EFSA¼European Food Safety Authority.
Harvey et al JPGN  Volume 65, Number 3, September 2017The median daily intake of energy ranged between 467 and
588 kcal/day in boys and between 421 and 515 kcal/day in girls
younger than 6 months of age, that is, below the age-group specific
estimated energy requirement (EER) (Supplemental Digital Con-
tent 5, Table 4, http://links.lww.com/MPG/B22). For infants older
than 6 months, the gap between energy intake from formula and
EER was bigger. This was especially true for boys age 10 and
12 months who met approximately 60% of their EER from formula
(vs 94% at 0–3 months), compared with 80% in girls of the same
age (vs 85% at 0–3 months).
The median intakes of the minerals for subjects below
6 months are presented in Table 2. Full intake distributions for
all ages are provided in Supplemental Digital Content 6, Table 5,
http://links.lww.com/MPG/B23. For all minerals, median intakes of
infants age 0 to 6 months was above the AI, indicating a low
prevalence of inadequate intakes (Table 2). For calcium and
phosphorus (Supplemental Digital Content 6, Table 5A and B,
http://links.lww.com/MPG/B23), median intakes from formula in
both boys and girls age 7 to 12 months was above the AI indicating a
low prevalence of inadequate intakes. For iron (Supplemental
Digital Content 6, Table 5C, http://links.lww.com/MPG/B23),
median intakes from formula alone in boys and girls age 7
to 12 months was above or close to the AI defined by the EFSA
(8 mg/day) and median intakes from formula and complementary
foods was above or close to the AI defined by the IOM (11 mg/day).
Overall, suggesting a low prevalence of inadequate iron intake.
Median sodium intakes from formula alone ranged between
164 and 209 mg/day in 7 to 12-month-old boys and between 187 and
254 mg/day in 7 and 12-month-old girls. Taking intake from
complementary foods into account resulted in an increase of the
median intake to the range of 424 to 614 mg/day for boys and 432 to
659 mg/day for girls (Supplemental Digital Content 6, Table 5E,
http://links.lww.com/MPG/B23), that is, a level above the AI of 170
to 370 mg/day, indicating a low prevalence of inadequate sodium
intake. For chloride, potassium and magnesium (Supplemental
Digital Content 6, Table 5D to G, http://links.lww.com/MPG/
B23), median intakes of formula alone in 7 to 12-month-olds were
below the AI and therefore no statement about the prevalence of
inadequate intakes could be made. Due to the absence of data in the
UK Diet and Nutrition Survey, intake from complementary foods
could not be considered for these minerals.DISCUSSION
The present study shows that AAF with or without synbio-
tics, which have been reported previously to be equally tolerated
and support normal growth (3,4), as part of an age-adapted diet, are348effective in providing an adequate mineral intake and status in
CMA infants.
The vast majority of infants age 0 to 6 months (formula only)
and age 7 to 12 months (formula and complementary foods) had
mineral intakes above the AI, indicating a high likelihood of
achieving adequate intakes. For those infants with a mineral intake
below the AI, this was related to a lower formula volume intake
compared with what would have been expected based on the
infant’s EER (data not shown). Intake levels of calcium and
phosphorus from formula alone were far above AIs set by the
EFSA and IOM, especially in the first half year of infants’ life. The
AAF used in this study is suitable for the whole first year of life, thus
including the weaning period. The level of calcium and phosphorus
in the AAF should therefore compensate for the low intakes of these
nutrients in the merely dairy-free complementary diet of CMA
infants. Moreover, compared with other countries (15) or Institutes
(16), EFSA, and IOM set relatively low AIs for calcium and
phosphorus. Neither the IOM (12,13) nor the EU Scientific Com-
mittee on Food (17) set a Tolerable Upper Intake Level (UL) of
calcium and phosphorus for infants, but the P95 intake levels of
both minerals remain far below the ULs of calcium and phosphorus
for children age 1 to 3 years. Calcium and phosphorus levels in the
study formulae comply with all compositional standards for infant
formula applicable in the USA, EU, China, and Brazil.
Mineral status was within reference ranges for the vast
majority of infants. At baseline, a few infants had individual blood
mineral concentrations below reference ranges, whereas at week 16
all mineral concentrations, with the exception of ferritin, were within
the age-specific range. Serum ferritin concentrations decreased
during the study, a phenomenon also seen in healthy infants as they
grow older (18). Prevalence of depleted iron stores (serum ferritin
<12mg/L (19)) found after 16 weeks of study, that is, 22%, are
similar to those found in healthy infants (20). Other indices for
assessing iron status, such as hematocrit, mean corpuscular volume,
and total iron binding capacity, were all within reference ranges for
age (data not shown) (3). Serum phosphorus concentrations also
dropped slightly over the time of the study, in line with documented
declines in phosphorus concentrations from 6 to 12 months of age
(21), but remained above age-specific reference ranges.
This study has some limitations. First, the high number of
subjects (40%) not available for analysis of the blood parameters.
Baseline characteristics of the dropouts were comparable to the
subjects included in the final analysis and the dropout rate was equal
in both study arms. Therefore, it is not likely that this has influenced
our findings. Secondly, in our study, some infants were already
receiving an AAF at enrolment, and thus, baseline blood values
cannot be strictly considered as ‘‘before intervention’’ values.www.jpgn.org
JPGN  Volume 65, Number 3, September 2017 Mineral Intake and Status in Cow’s Milk AllergyNevertheless, according to the study aim, the present analyses provide
evidence that after 16 weeks of management with an AAF, mineral
status of all participating infants was adequate. Finally, the use of the
UK Diet and Nutrition Survey (14) has a limitation since it only
presents data for a selected number of minerals. Moreover, estimates
of nutrient intakes from complementary foods from this survey
including healthy infants may be an overestimate for CMA infants
given that food intakes overall may be poorer and consequences of
excluding milk from the diet affects consumption of other food
groups, such as breakfast cereals. This survey data have been used
as a reasonable approximation in the absence of data on intakes of
complementary foods by CMA infants.
In conclusion, these data further contribute to the knowledge
about nutritional status and disease management of CMA infants
by showing that an AAF with or without synbiotics is effective in
providing an adequate mineral status in these infants. To assure
normal-for-age mineral status by all CMA infants, it is necessary
to provide them with regular medical and nutritional care
to ensure adequate formula intakes and, if needed, additional
supplementation.
REFERENCES
1. Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization
(WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy
(DRACMA) Guidelines. World Allergy Organ J 2010;3:57–161.
2. Vandenplas Y, Koletzko S, Isolauri E, et al. Guidelines for the diagnosis
and management of cow’s milk protein allergy in infants. Arch Dis Child
2007;92:902–8.
3. Burks AW, Harthoorn LF, Van Ampting MT, et al. Synbiotics-supple-
mented amino acid-based formula supports adequate growth in cow’s
milk allergic infants. Pediatr Allergy Immunol 2015;26:316–22.
4. Harvey BM, Langford JE, Harthoorn LF, et al. Effects on growth and
tolerance and hypoallergenicity of an amino acid-based formula with
synbiotics. Pediatr Res 2014;75:343–51.
5. Niggemann B, Binder C, Dupont C, et al. Prospective, controlled, multi-
center study on the effect of an amino-acid-based formula in infants with
cow’s milk allergy/intolerance and atopic dermatitis. Pediatr Allergy
Immunol 2001;12:78–82.
6. Mofidi S. Nutritional management of pediatric food hypersensitivity.
Pediatrics 2003;111 (6 pt 3):1645–53.
7. Duggan C, Watkins JB, Walker WA. Nutrition in Pediatrics. Ontario,
Canada: BC Decker Inc Hamilton; 2008.www.jpgn.org8. Scientific Advisory Committee on Nutrition (SACN). Dietary Reference
Values for Energy. London, UK: The Stationery Office (TSO); 2011.
9. US Institute of Medicine. Dietary Reference Intakes for Energy,
Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino
Acids (Macronutrients). Washington, D.C: The National Academies;
2005.
10. van Rossum CTM, Fransen HP, Verkaik-Kloosterman J, et al. Dutch
National Food Consumption Survey 2007–2010. Diet of children and
adults aged 7 to 69 years. Bilthoven, The Netherlands: National Institute
for Public Health and the Environment; 2011.
11. EFSA Panel on Dietetic Products Nutrition and Allergies (NDA).
Scientific Opinion on Dietary Reference Values for fats, including
saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty
acids, trans fatty acids, and cholesterol. EFSA J 2010;8:1461.
12. US Institute of Medicine. Dietary Reference Intakes: The Essential
Guide to Nutrient Requirements Washington, DC: T.N. Academies;
2006.
13. US Institute of Medicine. Dietary Reference Intakes for Calcium and
Vitamin D.The National Academies; 2011.
14. NatCen/UCL/MRC. In: Bates B, Lennox A, Swan eds G, eds. National
Diet and Nutrition Survey Year 1 and 2 of Rolling Program, 2008–2010.
London, UK: NatCen/UCL/MRC; 2011.
15. Department of Health. Dietary Reference Values for Food Energy and
Nutrients for the United Kingdom. Report of the Panel on Dietary
Reference Values of the Committee on Medical Aspects of Food Policy.
Report on Health and Social Subjects.London, UK; 1991.
16. Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral
Requirements. Vitamin and Mineral Requirements in Human Nutrition.
Geneva, Switzerland: World Health Organization and Food and Agri-
culture Organization of the United Nations; 2004.
17. Scientific Committee on Food, Scientific Panel on Dietetic Products,
Nutrition and Allergies. Tolerable Upper Intake Levels for Vitamins and
Minerals. Parma, Italy: European Food Safety Authority; 2006.
18. Szymlek-Gay EA, Ferguson EL, Heath AL, et al. Food-based strategies
improve iron status in toddlers: a randomized controlled trial. Am J Clin
Nutr 2009;90:1541–51.
19. WHO/UNICEF/UNU. Iron Deficiency Anaemia—Assessment, Pre-
vention and Control. A Guide for Programme Managers. Geneva,
Switzerland: WHO/UNICEF/UNU; 2001:1–132.
20. Eussen S, Alles M, Uijterschout L, et al. Iron intake and status of
children aged 6–36 months in Europe: a systematic review. Ann Nutr
Metab 2015;66:80–92.
21. US Institute of Medicine. Dietary Reference Intakes for Calcium,
Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington,
D.C: The National Academies; 1997.349
